Hong Kong Exchange Explores New Biotech Initiatives, 2nd Largest Biotech Fundraising Hub with 73 IPOs Raising $29.2 Billion
9th September 2021 | Hong Kong
Hong Kong Exchange (HKEX) has signed a a Memorandum of Understanding (MOU) with Hong Kong Science and Technology Parks Corporation (HKSTP) to explore new biotech and fintech initiatives. Hong Kong Exchange (HKEX) will gain access to HKSTP’s deep pool of biotech industry experts to assist in its review of biotech listing applications, helping to maintain HKEX’s robust standards of investor protection and leadership as the world’s number 2 biotech funding hub. In 2019, Hong Kong Exchange (HKEX) had allowed the the listings of pre-revenue biotech issuer, helping Hong Kong to become the world’s second-largest biotech fundraising hub with 73 healthcare and biotech IPOs that had raised $29.2 billion (HKD 227 billion). As of August 2021, over 50 healthcare companies had submitted listing applications to Hong Kong Exchange (HKEX). (IPO ~ Initial Public Offering)
“ Hong Kong Exchange Explores New Biotech Initiatives, World’s 2nd Largest Biotech Fundraising Hub with 73 IPOs Raising $29.2 Billion “
Hong Kong Science and Technology Parks Corporation (HKSTP) has created a unique biomedical technology development platform combining world-class infrastructure and incubation programmes, supporting companies with funding, research and development, product development and commercialisation. HKSTP now supports over 150 biotech companies covering medical devices, diagnostics, therapeutics and personal care, as well as regenerative and traditional Chinese medicine, representing a full spectrum of tech-driven healthcare solutions.
HKEX Chief Executive Officer, Nicolas Aguzin:
“We are delighted to be teaming up with HKSTP, a uniquely Hong Kong institution known for its innovation and expertise, to help drive the continued development of the city’s fast-growing biotech and new economy ecosystem.
We look forward to working together, collaborating to realise our shared commitment to the community, which is to help support the growth aspirations of the leading companies of tomorrow.”
HKSTP Chief Executive Officer, Albert Wong:
“HKSTP firmly believes biomedical technology and fintech to be core pillars for Hong Kong’s innovation-driven future and this exciting partnership with HKEX brings us even closer to realizing this vision. This partnership creates the ideal investment platform and innovation ecosystem for the best local and international ventures to succeed and elevate Hong Kong’s position as a global biotech and fintech leader.”
Hong Kong:
- Hong Kong SFC Suspends Former Emperor Securities Licensed Representative for 2 Years for Misconduct
- Hong Kong SFC Warns Public On Unauthorised Collective Investment Schemes, Publishes Alert List
- Hong Kong SFC and Police Searched Listed Company Office & Residences for $57.9 Million Corporate Fraud, Arrests 2 for Money-Laundering
- Hong Kong Exchange Launches MSCI China A 50 Connect Index, Gives Investors Additional Tool to Manage Portfolio Risks
- Hong Kong SFC to Require Fund Managers to Include Climate into Investment & Risk Management Process, Starts from August 2022
- Hong Kong SFC 2021 Q2 Report: Actions on Market Misconduct, $640,000 Fines, 47527 Licensees, ESG Guidelines for Asset Managers
- Hong Kong SFC & ICAC Arrests Former Senior Executive of Listed Company for Suspicious Loan Activities
- Hong Kong & Singapore Increases 2021 GDP Forecast to 6.5% and 7%, Total AUM at $7.97 Trillion
- Hong Kong SFC to Require Investor Identification for Securities Trading in 2022, Reporting of OTC Transactions in 2023
- Hong Kong SFC Fines UBS $1.49 Million for Failure to Disclose Conflict of Interests, Risks and to Qualify Clients
- Hong Kong SFC 2020 Report: Asset and Wealth Management in Hong Kong
- Family Office Association Hong Kong Membership AUM Reaches $50 Billion, Appoints New Board Advisors and Sub-Committees
- Hong Kong SFC and Corruption Agency ICAC Crackdown on Stock Manipulation, Arrest Listco & Search IPO Underwriter
- Hong Kong Launches Family Office Hub, Promote Hong Kong to Family Offices Worldwide
- Hong Kong Exchange Setup China Advisory Group, Ex-Goldman Sachs China Chairman, Hillhouse Group, PAG Group
- Hong Kong Exchange Shortens IPO Process, Settlement Cycle from 5 Days to 2 Days
- Hong Kong Exchange New CEO Nicolas Aguzin Starts 3-Year Term
- Hong Kong Exchange Appoints JP Morgan International Private Bank CEO Nicolas Aguzin as New CEO
- Hong Kong Exchange to Launch New Hang Seng TECH Index Futures & Options
- Hong Kong SFC and Stock Exchange to Tackle IPO Misconduct, Inflated IPO Prices to Meet Listing Requirements
- Hong Kong Private Equity Funds to Have 0% Tax for Carried Interest
- 150 Stocks Suspended Trading on Hong Kong Stock Exchange for Missing Filing Deadline
- Hong Kong SFC: Police Arrested 12 People Suspected of Ramp & Dump Manipulation Schemes
- Hong Kong SFC Issues Restriction Notices to 13 Brokers for 54 Accounts Related to Social Media Scam
- Hong Kong & Singapore Regulators Warn Investors of Increased Trading Risks Triggered by Social Media & Online Forums
- Hong Kong SFC Warns of Investment Scams on Social Media Platforms
- Singapore Exchange Issues Alert on Stocks Trading Scam in Chat Groups
More:
- 2020 Top 10 Stock Exchange in the World
- 150 Stocks Suspended Trading on Hong Kong Stock Exchange for Missing Filing Deadline
- New York Stock Exchange Remains Market Leader for IPO in 2020, Raising $81.8 Billion
- Shanghai Stock Exchange is Now the World’s 3rd Largest Stock Exchange
- Tokyo Stock Exchange Halted Trading on 1st Oct Due to Technical Glitch, Resume on 2nd Oct
- Baidu IPO on Hong Kong Exchange, Price Remains Unchanged on Day 1
About HKEX
Hong Kong Exchanges and Clearing Limited (HKEX) is one of the world’s major exchange groups, and operates a range of equity, commodity, fixed income and currency markets. HKEX is the world’s leading IPO market and as Hong Kong’s only securities and derivatives exchange and sole operator of its clearing houses, it is uniquely placed to offer regional and international investors access to Asia’s most vibrant markets.
HKEX is also the global leader in metals trading, through its wholly owned subsidiaries, The London Metal Exchange (LME) and LME Clear Limited. This commodity franchise was further enhanced with the launch of Qianhai Mercantile Exchange (QME), in China, in 2018.
HKEX launched the pioneering Shanghai-Hong Kong Stock Connect programme in 2014, further expanded with the launch of Shenzhen Connect in 2016, and the launch of Bond Connect in 2017.
Visit: www.hkexgroup.com
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 10,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2023 Investment Day
- 28th March 2023 - Hong Kong
- 4th April 2023 - Singapore
- April 2023 - Virtual
- 6th June 2023 - Hong Kong
- 13th June 2023 - Singapore
- Sept 2023 - Hong Kong
- Oct 2023 - Singapore
- Oct 2023 - Hong Kong
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Investment Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
